Media, messages, and medication: strategies to reconcile what patients hear, what they want, and what they need from medications

R. Kravitz,R. Bell

DOI: https://doi.org/10.1186/1472-6947-13-S3-S5

IF: 3.298

2013-12-06

BMC Medical Informatics and Decision Making

Abstract:

What problem does this paper attempt to address?

Dehydro-oestriol and dehydropregnanetriol are candidate analytes for prenatal diagnosis of Smith-Lemli-Opitz syndrome

C H Shackleton,E Roitman,L Kratz,R Kelley

DOI: https://doi.org/10.1002/1097-0223(200103)21:3<207::aid-pd27>3.0.co;2-i

Abstract:Gas chromatographic/mass spectrometric (GC/MS) analysis of maternal urine and serum steroids from 13 pregnancies at 25% risk for Smith-Lemli-Opitz syndrome (SLOS) was undertaken. All patients were between 12 and 31 weeks' gestational age. From dehydrocholesterol/cholesterol ratios determined in amniotic fluid and chorionic villus cells, five patients were shown to carry SLOS affected fetuses and eight patients were negative for the condition. Because it had previously been shown that dehydro-oestriol and dehydropregnanetriol were novel steroids produced in SLOS, these compounds were measured in the serum and urine samples of the 13 mothers. All five urine samples from SLOS affected pregnancies had high levels of both dehydrosteroid metabolites, which were below the detection limit in the non-affected pregnancies. The ratios of dehydro-oestriol/oestriol (DHE(3)/E(3)) were between 0.073 and 1.42 for the affected patients and less than 0.01 for unaffected patients. Corresponding values for dehydropregnanetriol/pregnanetriol (DHPT/PT) were 0.037-1.02 for affected and less than 0.01 for unaffected. In the positive serum sample available for analysis, the DHE(3)/E(3) ratio was 0.20 [unaffected (n=5), <0.014]. It is proposed that the measurement of DHE(3) and DHPT in maternal urine and serum may allow non-invasive antenatal diagnosis of SLOS.
Maternal urinary steroid profiles in prenatal diagnosis of Smith-Lemli-Opitz syndrome: first patient series comparing biochemical and molecular studies

A Jezela-Stanek,E M Małunowicz,E Ciara,E Popowska,B Goryluk-Kozakiewicz,K Spodar,M Czerwiecka,J Jezuita,M J M Nowaczyk,M Krajewska-Walasek

DOI: https://doi.org/10.1111/j.1399-0004.2006.00551.x

Abstract:Smith-Lemli-Opitz syndrome (SLOS) is an autosomal recessive disorder caused by reduced activity of 7-dehydrocholesterol (7DHC) reductase, resulting in a decreased level of cholesterol and increased concentrations of 7DHC and 8DHC in body fluids and tissues. Ten pregnancies at 25% risk of SLOS underwent prenatal testing. Diagnostic studies included DHCR7 mutation analysis in chorionic villus samples, amniotic fluid sterol analysis and serial measurements of oestriol (E3), pregnanetriol (PT), 7-dehydropregnanetriol (7DHPT) and 8-dehydroesteriol (8DHE3) concentrations in maternal urine samples obtained between 9 and 20 weeks of gestation. All tests were diagnostic and revealed nine unaffected foetuses (two normal homozygotes and seven DHCR7 heterozygotes) and one affected foetus. In the affected pregnancy, 7DHC and 8DHC in amniotic fluid were 9.87 and 3.7 microg/ml, respectively [reference range (RR) 0.0026 +/- 0.0015 microg/ml and not detectable, respectively] and maternal urinary steroid analyses showed increased ratios of 7DHPT/PT and 8DHE3/E3 of 0.74 and 1.7, respectively (RR 0-0.0147 and 0-0.019). In the heterozygous foetuses, 7DHPT/PT and 8DHE3/E3 ratios did not exceed those found in 48 normal controls. This is the first series of prenatal diagnostic testing for SLOS where non-invasive biochemical testing was performed in tandem with invasive diagnostic testing. We conclude that steroid measurements in maternal urine are a reliable means of prenatal diagnosis for SLOS.
Midgestational maternal urine steroid markers of fetal Smith-Lemli-Opitz (SLO) syndrome (7-dehydrocholesterol 7-reductase deficiency)

C H Shackleton,E Roitman,L E Kratz,R I Kelley

DOI: https://doi.org/10.1016/s0039-128x(99)00026-4

IF: 2.76

Steroids

Abstract:Smith-Lemli-Opitz syndrome (SLOS) is a malformation syndrome associated with 7-dehydrocholesterol (7DHC) 7-reductase deficiency. Although SLOS can be detected in an affected fetus before midpregnancy by measurement of 7DHC levels in amniotic fluid or chorionic villus cells, a noninvasive, more routine method is needed. Accordingly, this study was instigated to search for specific steroids in maternal urine in an affected pregnancy that reflect the 7-reductase deficiency of the fetus, ie, steroids retaining 7,8-unsaturation. Steroids were characterized by gas chromatography/mass spectrometry after urinary extraction, conjugate separation, and derivatization. Most steroids in maternal urine from a patient carrying a SLOS fetus were identified as progesterone metabolites, and these were entirely conventional, showing no evidence of additional unsaturation. Unsaturated homologues of the cortisol metabolites were also not detected. However, unsaturated homologues of pregnane-3,16,20-triols and pregnane-3,17,20-triol were found. Most likely, these are 7,8-unsaturated homologues, but 8,9-unsaturation is also possible because of the known activity of delta7-delta8-isomerase on 7DHC, which results in 8DHC being a prominent sterol in SLOS. Among these novel human steroids, the following were provisionally characterized: 5beta-pregn-7(or 8)-ene-3alpha,17alpha,20alpha-triol, 5beta-pregn-7(or 8)-ene-3alpha,16alpha,20alpha-triol, and 5alpha-pregn-7(or 8)-ene-3,16alpha,20alpha-triol. Confirmation of the position of unsaturation will require steroid synthesis. These novel steroids are not present in normal pregnancy urine and, therefore, are valuable for prenatal diagnosis of SLOS. In addition, separate studies have shown that 5beta-pregn-7(or 8)-ene-3alpha,17alpha,20alpha-triol is present in urine of children and adults with SLOS, and so is a useful analyte for confirmation of the disorder throughout life.
Potential of sterol analysis by liquid chromatography-tandem mass spectrometry for the prenatal diagnosis of Smith-Lemli-Opitz syndrome

William J Griffiths,Yuqin Wang,Kersti Karu,Emmanuel Samuel,Shane McDonnell,Martin Hornshaw,Cedric Shackleton

DOI: https://doi.org/10.1373/clinchem.2007.100644

Abstract:Background: Smith-Lemli-Opitz syndrome (SLOS), a severe disorder of cholesterol synthesis, is classically diagnosed prenatally by GC-MS analysis of sterols in amniotic fluid. Considering the current trend toward tandem mass spectrometry (MS/MS) methodologies, we developed prototype LC-MS/MS methods for accurate diagnosis of the disorder. Methods: 3beta-Hydroxysterols in amniotic fluid are oxidized with cholesterol oxidase to their corresponding 3-ketones, which are then derivatized with Girard P (GP) hydrazine in a "one-pot" reaction. The resulting GP-hydrazones give an improved response in electrospray (ES)-MS/MS owing to the presence of a charged quaternary nitrogen and are analyzed by reversed-phase LC-ES-MS/MS. Both capillary and conventional LC-MS/MS formats are suitable, and the method is also applicable to paper-absorbed blood spots. Results: In a double-blind analysis of 18 amniotic fluid samples comprising 6 SLOS and 12 controls, the ratio of 7 + 8-dehydrocholesterol (7 + 8-DHC) to cholesterol was <0.02 [range 0.00-0.02, mean (SD) 0.01 (0.007)] in all control samples (intraassay variation 5.91%) and >0.20 [0.20-1.13, 0.79 (0.35)] in SLOS (intraassay variation 4.56%), corresponding to a difference in ratios between the 2 groups of at least a factor of 10. The limit of quantification was equivalent to that of 2 nL amniotic fluid injected on-column. Conclusions: We describe a proof-of-concept for the prenatal diagnosis of SLOS. Further developments will be necessary to automate sample handling and reduce chromatographic time for the methodology to be used in pre- and postnatal diagnosis.
Solvent and mutation effects on the nucleation of amyloid beta-protein folding.

L. Cruz,B. Urbanc,J. Borreguero,N. Lazo,D. Teplow,E. Stanley

DOI: https://doi.org/10.1073/pnas.0509276102

2005-10-26

Abstract:Experimental evidence suggests that the folding and aggregation of the amyloid beta-protein (Abeta) into oligomers is a key pathogenetic event in Alzheimer's disease. Inhibiting the pathologic folding and oligomerization of Abeta could be effective in the prevention and treatment of Alzheimer's disease. Here, using all-atom molecular dynamics simulations in explicit solvent, we probe the initial stages of folding of a decapeptide segment of Abeta, Abeta(21-30), shown experimentally to nucleate the folding process. In addition, we examine the folding of a homologous decapeptide containing an amino acid substitution linked to hereditary cerebral hemorrhage with amyloidosis-Dutch type, [Gln-22]Abeta(21-30). We find that: (i) when the decapeptide is in water, hydrophobic interactions and transient salt bridges between Lys-28 and either Glu-22 or Asp-23 are important in the formation of a loop in the Val-24-Lys-28 region of the wild-type decapeptide; (ii) in the presence of salt ions, salt bridges play a more prominent role in the stabilization of the loop; (iii) in water with a reduced density, the decapeptide forms a helix, indicating the sensitivity of folding to different aqueous environments; and (iv) the "Dutch" peptide in water, in contrast to the wild-type peptide, fails to form a long-lived Val-24-Lys-28 loop, suggesting that loop stability is a critical factor in determining whether Abeta folds into pathologic structures.
Prenatal diagnosis of the RSH/Smith-Lemli-Opitz syndrome

L E Kratz,R I Kelley

1999-02-19

Abstract:The RSH/Smith-Lemli-Opitz syndrome (RSH/SLOS) is a relatively common, autosomal recessive malformation syndrome comprising distinctive facial, limb and genital anomalies, and mental retardation. Most patients with a clinical diagnosis of RSH/SLOS have a defect of cholesterol biosynthesis at the level of 3beta-hydroxysteroid-delta7-reductase, resulting in a decreased level of cholesterol and an increased level of 7-dehydrocholesterol (7DHC) in body fluids and tissues. We report on our experience with the prenatal diagnosis of RSH/SLOS by quantitative sterol chromatography in amniotic fluid (AF) and chorionic villus (CV). Of 76 AF and nine CV samples analyzed for various indications, 20 were diagnostic of RSH/SLOS based on an increased level of 7DHC in the fluid or tissue. Of 39 fetuses at a 25% risk for RSH/SLOS, 10(25.6%) were affected. Twenty-nine pregnancies not known to be at risk for RSH/SLOS were studied because of either a fetal abnormality characteristic of RSH/SLOS detected by ultrasound, a low maternal serum uE3 level (MSuE3), or both. None of the pregnancies tested, because of a low MSuE3 but lacking a sonographic abnormality characteristic of RSH/SLOS, was affected. However, three of four pregnancies with a low MSuE3 and an RSH/SLOS-type fetal abnormality were positive. RSH/ SLOS was diagnosed in two additional pregnancies on which MSuE3 data were not available but in which fetal anomalies were identified. Of these five RSH/SLOS fetuses identified in pregnancies not otherwise at risk for RSH/SLOS, the presenting sonographic anomaly was either polydactyly, ambiguous genitalia, or both. Evaluation of the biochemical parameters and clinical severity of RSH/SLOS showed that there was an inverse correlation between clinical severity and both the level of AF 7DHC and the level of MSuE3. Based on these earlier and more extensive studies, we conclude that accurate prenatal diagnosis of RSH/ SLOS is possible by sterol analysis of AF and, most likely, CV specimens as well. Furthermore, our findings suggest that MSuE3 levels in combination with sonography may provide useful diagnostic and prognostic information in the absence of a family history of RSH/SLOS.
Prenatal presentation and diagnostic evaluation of suspected Smith-Lemli-Opitz (RSH) syndrome

Dorothea Haas,Gisela Haege,Georg F Hoffmann,Peter Burgard

DOI: https://doi.org/10.1002/ajmg.a.35837

Abstract:Smith-Lemli-Opitz (SLOS), or RSH syndrome, is an autosomal recessive deficiency of 7-dehydrocholesterol reductase (DHCR7) resulting in an accumulation of 7- and 8-dehydrocholesterol (7- and 8-DHC) in tissues and body fluids. At birth patients have variable malformations of CNS, heart, kidney, genitalia, and limbs, which may be life-limiting. In later course, psychomotor and mental retardation and behavior abnormalities become evident. Prenatally SLOS can be suspected on the basis of malformations and intrauterine growth retardation (IUGR) in prenatal ultrasonography and reduced maternal free estriol in serum. The diagnosis is confirmed by sterol analysis in a chorionic villus biopsy or amniotic fluid (AF). In this study, we evaluated the predictive value of the above mentioned criteria in combination with family history by quantification of sterols in AF in pregnancies with either a family history, ultrasonographical abnormalities typical for SLOS, or reduced maternal serum unconjugated estriol (MSuE3). The relative frequency of SLOS in fetuses with an affected sibling was 0.23, as to be expected for an autosomal recessive disease. The probability for SLOS was <0.6% when neither an affected sib nor more than one typical SLOS malformation was present. For safety reasons and for cost-effectiveness we recommend careful evaluation of history, MSuE3, and clinical presentation before determining sterols in AF.
Functional coupling of neonatal rat Sertoli cells and gonocytes in coculture.

J. Orth,R. Boehm

DOI: https://doi.org/10.1210/ENDO-127-6-2812

IF: 5.051

1990-12-01

Endocrinology

Abstract:Interaction between Sertoli cells and germ cells is likely to be critical for normal development of the testis. We have established and characterized cocultures of neonatal Sertoli cells and gonocytes and have begun to study the physical and functional relationship between these cells in vitro. Cells were isolated from rat pups by sequential enzymatic treatment and cultured in serum-free medium. When plated on Matrigel, Sertoli cells rapidly attach, and gonocytes adhere to the underlying Sertoli cells shortly thereafter. We observed that some of these germ cells develop cytoplasmic processes and elongate during the first day of culture, essentially mimicking their behavior in vivo. Electron microscopic examination of typical cultures revealed the presence of desmosome-like adhesion sites and apparent gap junctions between Sertoli cells and gonocytes. To determine whether Sertoli cells and gonocytes are functionally coupled in the cocultures, we used the glass bead-loading technique of McNeil and Warder to introduce Lucifer yellow (LY), a gap junction-permeant probe, and Rhodamine-dextran (RD), a larger marker excluded by gap junctions, simultaneously into cultures 24 h after plating. Immediate fixation and viewing of cultures with fluorescence microscopy indicated that all bead-loaded cells received both probes. We studied other living cultures 10 min after bead-loading and located RD-negative (i.e. nonbead-loaded) gonocytes that were in obvious contact with RD- and LY-positive bead-loaded Sertoli cells; these gonocytes were scored for the presence or absence of cytoplasmic LY. This analysis revealed that many gonocytes were able to obtain LY from adjacent Sertoli cells, presumably via gap junctions maintained with these cells. In addition, we quantified the percentage of gonocytes that elongated with increasing time in vitro and correlated the morphology of these cells with their ability to acquire LY from adjacent Sertoli cells. Our findings indicate that although the absolute numbers of gonocytes present decreases, more of those remaining elongate as time in vitro increases. We can also conclude from our data that gonocytes with and without processes are equally likely to be coupled with Sertoli cells under these conditions. These observations provide the first demonstration of functional coupling between Sertoli cells and premeiotic germ cells. Together with our morphological observations, they suggest that gap junction-mediated communication between these cells may be involved in stimulating or regulating changes in the gonocyte population during postnatal development of the testis.
Difficult prenatal diagnosis in mild Smith-Lemli-Opitz syndrome

M J Nowaczyk,T Heshka,L E Kratz,R E Kelley

2000-12-11

Abstract:Smith-Lemli-Opitz syndrome (SLOS) is an autosomal recessive disorder of cholesterol biosynthesis caused by mutations of the 7-dehydrocholesterol (7DHC) reductase gene (DHCR7). We present our experience with prenatal diagnosis of an affected fetus with a very mild form of SLOS. The mother underwent prenatal diagnosis by chorionic villus (CV) sampling at 11 2/7 weeks because of having two prior affected sons with SLOS. The 7DHC/total-sterol ratio in the fetus was higher than in normal control fetuses but lower than the ratio observed in CV of three other fetuses in whom SLOS was diagnosed prenatally. The pregnancy was terminated at 13 2/7 weeks. The level of 7DHC in amniotic fluid (AF) obtained at the time of pregnancy termination was unequivocally elevated, confirming the diagnosis of SLOS. This report illustrates the difficulties with the interpretation of biochemical prenatal diagnosis based on the determination of 7DHC/total-sterol ratio in CV sample in a case of mild SLOS, whereas biochemical testing of amniotic fluid clearly manifests the biochemical defects of SLOS as early as 13 weeks of gestation.
[RADIOCINEMATOGRAPHY OF DEGLUTITION IN THE INFANT AND GLOSSOPTOSIS].

A. Fontan,Berger,Pinsón,J. Battin

Abstract:
Differences between predicted and established diagnoses of Smith-Lemli-Opitz syndrome in the Polish population: underdiagnosis or loss of affected fetuses?

Aleksandra Jezela‐Stanek,Elżbieta Ciara,Ewa Małunowicz,Krystyna Chrzanowska,Anna Latos‐Bieleńska,Małgorzata Krajewska‐Walasek,The Smith‐Lemli‐Opitz syndrome Collaborative Group,Aleksandra Jezela-Stanek,,Anna Latos-Bieleńska,Małgorzata Krajewska-Walasek

DOI: https://doi.org/10.1007/s10545-010-9132-4

IF: 4.7501

2010-06-16

Journal of Inherited Metabolic Disease

Abstract:Smith-Lemli-Opitz syndrome (SLOS) is a metabolic disorder in which an error in cholesterol biosynthesis results in congenital anomalies/mental deficits. The results of our previous newborn screening, based on the carrier frequency of the two most common SLOS-causing mutations in Poland (p.W151X and p.V326L), would make SLOS one of the most frequent recessive disorders in our country (with an incidence of 1:2,300 - 1:3,937). This prompted us to carry out a 3-year (2006-2008) national surveillance program in which about 2,000 physicians were asked to identify potential SLOS patients pre- and postnatally based on clinical identification forms. The incidence of SLOS in Poland was estimated to be from 1:60,941 to 1:105,395 (1: 83,168 ± 22,227) live births, and its 3-year prevalence 1:866,273 ± 16,242. The mean carrier frequency was calculated to be from 1:123 to 1:165. The notable discrepancy between our previous carrier newborn screening and these prospective data may result from reduced fertility in SLOS carriers, intrauterine death of affected fetuses, or underdiagnosis in postnatal life. Since we did not notice significant data supporting the first two aspects, our study may support the suggestion that screening for the most frequent DHCR7 alleles does not reflect the true disease rates in the Polish population. Hence, further studies in which maternal urinary steroids (7-dehydroestriol/estriol and 8-dehydropregnanetriol/pregnanetriol ratios) would serve as screening markers in early pregnancies may be justified.

genetics & heredity,endocrinology & metabolism,medicine, research & experimental
[Intravesical bacillus Calmette-Guerin instillation therapy for carcinoma in situ of the urinary bladder and prediction of effects by urinary cytologic examination].

E. Satoh,H. Arai,Takayasu Gotoh,H. Miura,M. Honda,H. Fujioka,Takako Uraoka,M. Tsujimoto

DOI: https://doi.org/10.5980/JPNJUROL1989.90.901

1999-12-01

Abstract:PURPOSE We investigated the effects of intravesical BCG instillations for carcinoma in situ (CIS) of the urinary bladder. And we have retrospectively analyzed the prediction of effects by fresh urinary cytologic examinations before instillation. MATERIAL AND METHODS 33 patients were treated for bladder CIS (1991-1997) with a median follow-up of 30 months (range from 9 to 90 months). The patients (27 males and 6 females) ranged in age from 46 to 91 (average 71 years) and received 6 to 12 weekly BCG Tokyo 172 strain 80 mg instillations. They were divided into 3 groups based on tumor history: primary (9), secondary (15), concurrent (9). The prediction of effects were analyzed by scoring fresh urinary cytologic examinations before instillation. RESULTS 22 cases (67%) were responded and they have remained free of disease for follow-up period. The statistic evaluation proved to show the significance between the effects of treatment and the sum of scoring (cellular appearance and existence of large nuclear cells). CONCLUSION We confirmed the effects of this treatment. The prediction of effect of this treatment seemed to be indicative by fresh urinary cytologic examinations before instillation, especially cellular appearance and existence of large nuclear cells.
Effect of temperature on growth and activity of Aeromonas spp. and mixed bacterial populations in the Anacostia River

B. Cavari,D. Allen,R. Colwell

DOI: https://doi.org/10.1128/aem.41.4.1052-1054.1981

1981-04-01

Applied and Environmental Microbiology

Abstract:During the winter months, total bacterial counts in the water column and in the sediment in the Anacostia River were two- to eightfold higher than at other times of the year, whereas Aeromonas spp. decreased in number of several orders of magnitude. This significant decrease in number in the Anacostia River during the cold months of the year can be explained by the low metabolic activity of Aeromonas at low temperatures.
Changes in the lymphoid architecture of trypanosome infected mice.

K. Hudson,C. Byner

DOI: https://doi.org/10.1016/0035-9203(73)90170-3

Transactions of the Royal Society of Tropical Medicine and Hygiene

Abstract:
Holographic aspects of temporal memory and optomotor responses

A. Borsellino,T. Poggio

DOI: https://doi.org/10.1007/BF00288785

Kybernetik

Abstract:
Assessing Postnatal Mortality in Smith–Lemli–Opitz Syndrome

Aishwarya Selvaraman,Samar Rahhal,Simona Bianconi,Tristan Furnary,Forbes D. Porter

DOI: https://doi.org/10.1002/ajmg.a.63875

2024-09-15

American Journal of Medical Genetics Part A

Abstract:Smith–Lemli–Opitz syndrome (SLOS) is a rare autosomal recessive disorder caused by pathological variants in DHCR7, resulting in a deficiency in the enzyme 7‐dehydrocholesterol reductase. This results in elevated levels of cholesterol precursors and typically low cholesterol levels, leading to a range of physical and cognitive challenges. Mortality rates in infants with severe SLOS are high, due to congenital malformations. Premature death has been described in individuals with SLOS, particularly in severely affected individuals. Further research is needed to understand postnatal mortality risk factors for individuals with SLOS. Understanding these factors could improve monitoring and prevention efforts. To investigate this, we obtained death certificates from the National Death Index (NDI) database on a cohort of individuals with SLOS who were enrolled in natural history studies at the National Institutes of Health Clinical Center (NCT00001721 and NCT05047354). Analysis and comparison of this deceased cohort showed that although premature death occurs in SLOS, many individuals with SLOS survive into adulthood. We also observed the risk of postnatal mortality increasing with higher severity scores and lower initial cholesterol levels. Trial Registration: NCT00001721 and NCT05047354.

genetics & heredity
Origin of planktotrophy—evidence from early molluscs: a response to Nützel et al. (2006)

G. Freeman,Judith W. Lundelius

DOI: https://doi.org/10.1111/j.1525-142X.2007.00164.x

2007-07-01

Evolution & Development

Abstract:There have been recent speculations in the literature about the nature of the trophic mode of Early Paleozoic marine faunas. It has been proposed that lecithotrophy is the primitive trophic mode in Cambrian invertebrates and that a shift to planktotrophy took place during the Late Cambrian–Early Ordovician in response to predation pressure or changes in the plankton (Signor and Vermeij 1994; Peterson 2005). Nützel et al. (2006) attempt to provide empirical evidence for this hypothesis in the Mollusca by analyzing the apices of Cambrian and Ordovician steinkerns (natural casts) representing early ontogenetic stages. They describe the developmental criteria that define lecithotrophy and planktotrophy. In extant molluscs, a small shell is formed during embryogenesis that approximates the size of the egg (protoconch I). Lecithotrophs have only protoconch I; their eggs are larger than planktotrophic ones because they contain a greater amount of yolk to nourish the embryo until metamorphosis. Planktotrophs generally form a smaller protoconch I and an additional shell is laid down during an extended feeding larval phase (protoconch II); together, these two protoconchs will be larger than protoconch I (Jablonski and Lutz 1980). Each phase can usually be identified by changes in ornamentation and a discernable growth discontinuity on the shell. When the larva undergoes metamorphosis, there is yet another discontinuity and change in ornamentation. Nützel et al. use internal casts of the apices of molluscan shells of Cambrian and Ordovician/Silurian age to make inferences about the trophic state of molluscan larvae based on size differences of the protoconchs. The external shell surface that would show details of the actual protoconch has been dissolved away by either diagenetic processes or by acid preparation. To compensate for this loss of detail, they selected a distance of 100mm from the apex of the fossil and measured the diameter of the internal mold at that point. They claim that a diameter measurement at this length reflects the size of the protoconch as well as the amount of yolk and the ontogenetic strategy. No literature is cited to support this statement. They plotted a histogram of these diameters (their Fig. 3C), presumably as an approximation of the size of protoconch I, and concluded that the post-Cambrian protoconch diameters are smaller than the protoconchs of Cambrian specimens and thus represent the eggs of planktotrophs whereas the larger protoconchs of the Cambrian specimens were the consequence of yolkier lecithotrophic eggs. This result would provide factual support for the initial appearance of lecithotrophy in the Mollusca in the fossil record. To make the quantitative comparison that the Nützel et al. conclusion depends on, it is essential that the size comparison be made on equivalent protoconch stages and that the measurements be comparable estimates of protoconch size. Their methodology is problematic for several reasons: (1) Identifying and measuring protoconch I: Although they describe the development of protoconchs I and II and their significance, these distinctions are not used in evaluating their illustrated specimens or the measured samples. If the measurement protocol is applied to the specimen in their Fig. 1C, which has a bulbous apex that is probably protoconch I, there is a roughly 25% disparity between the diameter measurement made through the protoconch itself (59mm) and a diameter measurement made at 100mm from the apex (82mm), which is beyond the area of protoconch I (Fig. 1). A single diameter measurement is not a good approximation of size especially where there are significant differences in protoconch shape. (2) Comparing Cambrian and post-Cambrian samples: The crux of their argument is the diameter data graphed in their Fig. 3C taken from 110 Cambrian and Ordovocian/Silurian steinkerns that shows a significant size distinction between the Cambrian and Ordovician/Silurian specimens. Although they state that the sample is of gastropods and other univalve molluscs, they do not identify the taxa and how these measurements were distributed among the different classes of Lower Paleozoic molluscs. Univalve molluscs included the monoplacophorans Tergomya and Helcionellida, Rostroconchia, Gastropoda, and the closely related Hyolitha (Kouchinsky 2001). These groups had very different shell shapes that become evident at early stages of development. Gastropods and hyoliths have narrow, tubular shells where the aperture expands relatively slowly as the shell grows. The shells of monoplacophorans tend to have a bell shape and the aperture EVOLUTION & DEVELOPMENT 9:4, 307 –310 (2007)
Atypical case of Smith-Lemli-Opitz syndrome: implications for diagnosis

B Angle,G S Tint,O A Yacoub,A L Clark

1998-12-04

Abstract:Smith-Lemli-Opitz (SLO) syndrome is an autosomal recessive disorder comprised of recognizable facial abnormalities, growth retardation, and multiple congenital anomalies, commonly involving genitalia, second and third toe syndactyly, and cleft palate. The condition is associated with hypocholesterolemia and elevated levels of 7-dehydrocholesterol (7DHC) resulting from deficient activity of the enzyme 7-dehydrocholesterol reductase. The clinical spectrum of SLO ranges from individuals with mental retardation and minor anomalies to those with major structural defects and early or even prenatal lethality. Low maternal serum unconjugated estriol (uE3) levels and a variety of fetal ultrasound anomalies have been identified in affected pregnancies, and prenatal diagnosis is possible by measurement of amniotic fluid 7DHC levels in pregnancies known to be at risk because of a previously affected child. We report on a pregnancy with low maternal uE3 level, abnormal antenatal ultrasound findings including limb deformities, ventriculomegaly, and hydrops fetalis, and a normal 46,XY karyotype. The infant died at birth. At autopsy the infant had hydrops, unusual face, cleft palate, genital abnormalities, Dandy-Walker malformation, and absence of toe syndactyly. Tests performed on cultured skin fibroblasts showed elevated levels of 7DHC and abnormalities of cholesterol biosynthesis characteristic of the metabolic defect that causes SLO. The atypical findings of hydrops, uncharacteristic facial appearance, and absence of toe syndactyly in this case additionally illustrates the wide phenotypic spectrum of SLO and the need for a high index of suspicion for a disorder with great clinical variability. Identification of another affected pregnancy with a low maternal uE3 level and abnormal fetal ultrasound findings in the presence of a normal karyotype lends additional support for consideration of prenatal biochemical testing for SLO in pregnancies with these findings, including pregnancies not previously known to be at risk.
Hypophosphatemia in Hypercatabolic Patients

J. Takala,P. Neuvonen,J. Klossner

DOI: https://doi.org/10.1111/j.1399-6576.1985.tb02345.x

1985-12-01

Abstract:Twenty‐four hypercatabolic surgical intensive care patients were treated with a daily phosphate dosage of 0.5 mmol/kg b. wt during the postoperative total parenteral nutrition (TPN). The adequacy of this regimen was evaluated by measuring the plasma phosphate concentration before and after five days of TPN. All the patients were in negative nitrogen balance throughout the study. Ten of them were hypophosphatemic at the beginning, while none was hypophosphatemic at the end of the study. Hyperphosphatemia was observed once, at the end of the study. The catabolic surgical patient receiving parenteral nutrition is at risk of hypophosphatemia, and particularly vulnerable to its consequences. A daily dosage of 0.5 mmol/kg b. wt of phosphate appeared adequate in covering the increased requirements of these patients.
Regional distribution of endothelin receptor in porcine cardiovascular tissues

R. Takayanagi,T. Hashiguchi,M. Ohashi,H. Nawata

DOI: https://doi.org/10.1016/0167-0115(90)90043-V

1990-02-04

Regulatory Peptides

Abstract:

Media, messages, and medication: strategies to reconcile what patients hear, what they want, and what they need from medications

Dehydro-oestriol and dehydropregnanetriol are candidate analytes for prenatal diagnosis of Smith-Lemli-Opitz syndrome

Maternal urinary steroid profiles in prenatal diagnosis of Smith-Lemli-Opitz syndrome: first patient series comparing biochemical and molecular studies

Midgestational maternal urine steroid markers of fetal Smith-Lemli-Opitz (SLO) syndrome (7-dehydrocholesterol 7-reductase deficiency)

Potential of sterol analysis by liquid chromatography-tandem mass spectrometry for the prenatal diagnosis of Smith-Lemli-Opitz syndrome

Solvent and mutation effects on the nucleation of amyloid beta-protein folding.

Prenatal diagnosis of the RSH/Smith-Lemli-Opitz syndrome

Prenatal presentation and diagnostic evaluation of suspected Smith-Lemli-Opitz (RSH) syndrome

Functional coupling of neonatal rat Sertoli cells and gonocytes in coculture.

Difficult prenatal diagnosis in mild Smith-Lemli-Opitz syndrome

[RADIOCINEMATOGRAPHY OF DEGLUTITION IN THE INFANT AND GLOSSOPTOSIS].

Differences between predicted and established diagnoses of Smith-Lemli-Opitz syndrome in the Polish population: underdiagnosis or loss of affected fetuses?

[Intravesical bacillus Calmette-Guerin instillation therapy for carcinoma in situ of the urinary bladder and prediction of effects by urinary cytologic examination].

Effect of temperature on growth and activity of Aeromonas spp. and mixed bacterial populations in the Anacostia River

Changes in the lymphoid architecture of trypanosome infected mice.

Holographic aspects of temporal memory and optomotor responses

Assessing Postnatal Mortality in Smith–Lemli–Opitz Syndrome

Origin of planktotrophy—evidence from early molluscs: a response to Nützel et al. (2006)

Atypical case of Smith-Lemli-Opitz syndrome: implications for diagnosis

Hypophosphatemia in Hypercatabolic Patients

Regional distribution of endothelin receptor in porcine cardiovascular tissues